Clinical Trial 49921

Sherman Oaks, CA 91403


Summary:

A PHASE III, MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND,PLACEBO-CONTROLLED STUDY TO EVALUATETHE EFFICACY AND SAFETY OFGANTENERUMAB IN PARTICIPANTS AT RISK FOR OR AT THE EARLIEST STAGES OF
ALZHEIMER’S DISEASE

You may be a candidate for a study of an investigational medication or placebo (inactive substance) in participants at risk of Alzheimer’s Disease.

 

 



Participant must have a reliable study partner.

Must be between ages of 60-80 without significant memory problems
• A single blood draw to test for blood-based biomarkers of Alzheimer’s Disease
• You would receive $50 for the BBBM (blood based biomarker) blood draw and information on whether you qualify for a study of those at risk or Alzheimer’s Disease.


Qualified Participants May Receive:

Compensation provided to Patient and the Study Partner as well


Available At:

California Neuroscience Research
4835 Van Nuys Blvd., Ste. 104
Sherman Oaks, CA 91403
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.